Events: detail
Biomarkers in Clinical Trials
- Hosted by:
- SMI Group
- Speaker:
-
Stefan Scherer, Global Biomarker Program Leader and Head of Biomarker Angiogenesis, F. Hoffmann-La Roche
Alessandra Vitaliti, Head of Cellular Biomarkers Group, Novartis
Stewart Bates, Director of Biomarker Discovery, GlaxoSmithKline
Paul de Koning, Vice President and Head of Exploratory Development, Astellas
Birgitte Søgaard, Divisional Director, Clinical Pharmacology and Translational Medicine, H. Lundbeck
Fernando Ulloa-Montoya, Biomarkers Leader, Cancer Immunotherapeutics R&D Department, GlaxoSmithKline Biologicals
Simon Read, Leader of Biomarkers and Experimental Medicine, Roche Pharmaceuticals
Stefan Sultana, Clinician and Translational Medicine Leader, Pfizer
Patrick Y. Mueller, Project Leader for Safety Assessment, Novartis Institutes for BioMedical Research
Rose McCormack, Clinical Research Scientist, Astrazeneca
Mauro D'Antonio, Manager of Biomarker Testing Platforms, Merck Serono
Feng Luo, Senior Scientist, Experimental Imaging, Abbott Laboratories
- Starts:
- September 22, 2009 at 08:30 am
- Ends:
- September 24, 2009 at 05:30 am
- Location:
- Crowne Plaza, St. James Hotel, 45-51 Buckingham Gate , London, SW1E 6AF United Kingdom
- Maps:
Description
With an exceptional line-up of speakers, SMi’s Biomarkers in Clinical Trials conference will demonstrate the way forward in designing phase I, II and III trials. Attend and gain insights into the use of biomarkers as a way of accelerating the approval or withdrawal of a product. You will have the chance to network with industry associates and the opportunity to explore ways in which you can integrate biomarkers into your own drug development processes. This unique event is designed to help you identify the potential of your products in the most efficient way possible and is an essential addition to the calendar of all those working in the industry.
- Registration required:
- Yes
- Free:
- No
Additional information
Why should you attend this event?
Understand the realities of biomarker application in late-stage drug development
Learn ways of adapting existing clinical trial models to integrate biomarkers
Hear about the potential financial benefits of using biomarkers
Determine what the most appropriate strategies are for your own development programmes
Network with industry associates and discuss various approaches to biomarker implementation
For more information
- Contact person:
- Zain Philbey
- Phone:
- +44 (0) 870 9090 711
- Email:
- zphilbey [ at ] smi-online.co.uk
- Website:
- Biomarkers in Clinical Trials
